501 related articles for article (PubMed ID: 18363292)
1. [The National Board of Health and Welfare's guidelines for prostatic cancer care. PSA test screening--only for well-informed men].
Bratt O; Damber JE; Kärvinge C; Malm T; Hensjö LO; Hyttsten E
Lakartidningen; 2008 Feb 20-26; 105(8):524-8. PubMed ID: 18363292
[No Abstract] [Full Text] [Related]
2. [Large part of Swedish men PSA tested for early prostatic cancer. Few aware of the disadvantages of the test].
Bratt O; Grenabo L
Lakartidningen; 2010 Feb 17-23; 107(7):432-5. PubMed ID: 20384075
[No Abstract] [Full Text] [Related]
3. [Legal (liability) aspects of PSA determination].
Mielke K
Urologe A; 2006 Jun; 45(6):756-65. PubMed ID: 16788794
[No Abstract] [Full Text] [Related]
4. [The PSA test does not hold for screening. Good--but not good enough].
Holmström B; Johansson M; Bratt O; Stattin P
Lakartidningen; 2010 Feb 17-23; 107(7):436, 438-9. PubMed ID: 20384076
[No Abstract] [Full Text] [Related]
5. Screening by the prostate-specific antigen test: what do the patients know?
Diefenbach PN; Ganz PA; Pawlow AJ; Guthrie D
J Cancer Educ; 1996; 11(1):39-44. PubMed ID: 8777154
[TBL] [Abstract][Full Text] [Related]
6. [PSA based screening for prostatic cancer].
Johansen TE
Tidsskr Nor Laegeforen; 2008 Nov; 128(22):2612-4. PubMed ID: 19023357
[No Abstract] [Full Text] [Related]
7. Should men be screened for prostate cancer?
Patel SM
N C Med J; 1999; 60(5):275-7. PubMed ID: 10495656
[No Abstract] [Full Text] [Related]
8. [PSA test inconvenience?].
Drøsdal HH
Tidsskr Nor Laegeforen; 2005 Mar; 125(5):623; author reply 623. PubMed ID: 15776048
[No Abstract] [Full Text] [Related]
9. AUA issues a policy report on PSA monitoring. The American Urological Association.
Scott Morey S
Am Fam Physician; 2000 Aug; 62(4):883-4. PubMed ID: 10969861
[No Abstract] [Full Text] [Related]
10. PSA level changes over time in men with an initial PSA level of < or = 4 ng/ml.
Bangma C
Nat Clin Pract Urol; 2006 Oct; 3(10):520-1. PubMed ID: 17031372
[No Abstract] [Full Text] [Related]
11. [The significance and limitation of prostate specific antigen in the mass screening for prostate cancer].
Imai K; Yamanaka H
Nihon Rinsho; 1998 Aug; 56(8):1994-7. PubMed ID: 9750494
[TBL] [Abstract][Full Text] [Related]
12. Update on screening for prostate cancer with prostate-specific antigen.
Schmid HP; Riesen W; Prikler L
Crit Rev Oncol Hematol; 2004 Apr; 50(1):71-8. PubMed ID: 15094160
[TBL] [Abstract][Full Text] [Related]
13. [Systematic PSA screening has been tried in Region Skåne. Balanced information gives chance for equal treatment according to a pilot project].
Bratt O; Lundgren R; Ahlgren G
Lakartidningen; 2012 Sep 12-18; 109(37):1610-2. PubMed ID: 23077769
[No Abstract] [Full Text] [Related]
14. [Mass screening for prostate cancer is the best approach to early diagnosis and treatment of prostate cancer].
Zhao XJ; Kong XB; Wang WH
Zhonghua Nan Ke Xue; 2003 Nov; 9(8):563-5, 568. PubMed ID: 14689882
[TBL] [Abstract][Full Text] [Related]
15. [Prostate-specific antigen--the most important cancer marker. Diagnostics and follow up of prostatic cancer have changed].
Bratt O; Björk T
Lakartidningen; 2007 Nov 14-20; 104(46):3460-4. PubMed ID: 18072615
[No Abstract] [Full Text] [Related]
16. [Based on current knowledge the introduction of the PSA screening for prostatic cancer is unethical].
Krantz I; Sachs L; Ahlberg BM; Nordin P; Nilstun T
Lakartidningen; 2005 Sep 5-11; 102(36):2498-500. PubMed ID: 16196436
[No Abstract] [Full Text] [Related]
17. [Comments on the PSA in primary health care: survey results in more "losers" than "winners"].
Bratt O
Lakartidningen; 2003 Nov; 100(48):4014-5. PubMed ID: 14717100
[No Abstract] [Full Text] [Related]
18. PSA screening: a view from the front lines. North York General-Branson Practice-Based Small Group.
Greiver M; Rosen N
CMAJ; 2000 Mar; 162(6):789-90. PubMed ID: 10750465
[No Abstract] [Full Text] [Related]
19. Is an improved PSA screening test in sight?
Savage L
J Natl Cancer Inst; 2007 Oct; 99(20):1503-4. PubMed ID: 17925529
[No Abstract] [Full Text] [Related]
20. Controversy over prostate-specific antigen screening has shifted from mortality to overtreatment issues.
Ito K
Int J Urol; 2009 Sep; 16(9):711-12. PubMed ID: 19777638
[No Abstract] [Full Text] [Related]
[Next] [New Search]
